Joyzyme Group Limited (HKG:8622)
0.3450
+0.0200 (6.15%)
Apr 2, 2026, 4:08 PM HKT
Joyzyme Group Market Cap
Joyzyme Group has a market cap or net worth of 177.84 million as of April 2, 2026. Its market cap has increased by 12.81% in one year.
Market Cap
177.84M
Enterprise Value
136.71M
Revenue
31.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.35
Market Cap Chart
Since December 13, 2018, Joyzyme Group's market cap has decreased from 188.00M to 177.84M, a decrease of -5.41%. That is a compound annual growth rate of -0.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 167.53M | -25.29% |
| Dec 31, 2025 | 224.23M | 198.69% |
| Dec 31, 2024 | 75.07M | 67.66% |
| Dec 29, 2023 | 44.78M | -41.60% |
| Dec 30, 2022 | 76.68M | -22.70% |
| Dec 31, 2021 | 99.20M | 131.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhongzhi Pharmaceutical Holdings | 699.52M |
| China NT Pharma Group Company | 692.77M |
| Wai Yuen Tong Medicine Holdings | 378.89M |
| Shenzhen Neptunus Interlong Bio-technique Company | 218.14M |
| Regent Pacific Group | 213.03M |
| Extrawell Pharmaceutical Holdings | 211.65M |
| Tianda Pharmaceuticals | 208.55M |
| Kontafarma China Holdings | 167.66M |